×

Tuesday, April 20, 2021
Advertisement
Tags Infectious Disease Society of America

Tag: Infectious Disease Society of America

Mumia’s fight for medical treatment

Protest Big Pharma’s price gouging that threatens Hep-C patients, including Mumia, on Monday, Jan. 11, 12 noon, at the JP Morgan Healthcare Conference for Big Pharma executives and investors at Westin St. Francis Hotel, 335 Powell St., Union Square, in San Francisco. Gilead Sciences sells the curative Harvoni pill in Egypt for 10 cents each, and Gilead does not lose money at this price. In the U.S., Gilead is price-gouging at about 10,000 times the cost of production!

Who gets hepatitis C drugs? Who pays?

“Who gets treated for hepatitis C?” is a medical decision for infectious disease specialists, not a question of “ethics, costs or access” for well-meaning executives. “Who pays?” depends on measuring the real social costs of failing to treat a national epidemic and cannot be measured by the limited considerations of private entities and public agencies in a single state, or even several states.